DocGo R&D Spending Growth & History (DCGO)
DocGo's r&d spending was $13.6M for fiscal 2025.
View full DocGo company overviewDocGo annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.6M | $2.0M | +17.03% |
| 2024 | 2024-12-31 | $11.6M | $730,678 | +6.73% |
| 2023 | 2023-12-31 | $10.9M | $5.5M | +101.65% |
| 2022 | 2022-12-31 | $5.4M | $2.1M | +62.19% |
| 2021 | 2021-12-31 | $3.3M | $2.1M | +179.10% |
| 2020 | 2020-12-31 | $1.2M | — | — |
DocGo quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.4M | $489,086 | +16.54% |
| Q1 2026 | 2026-03-31 | $3.7M | $65,605 | +1.80% |
| Q4 2025 | 2025-12-31 | $3.8M | $87,293 | +2.37% |
| Q3 2025 | 2025-09-30 | $3.2M | $47,646 | +1.51% |
| Q2 2025 | 2025-06-30 | $3.0M | $588,204 | +24.83% |
| Q1 2025 | 2025-03-31 | $3.6M | $1.3M | +52.35% |
| Q4 2024 | 2024-12-31 | $3.7M | $500,195 | +15.70% |
| Q3 2024 | 2024-09-30 | $3.1M | −$89,467 | −2.77% |
| Q2 2024 | 2024-06-30 | $2.4M | −$205,390 | −7.98% |
| Q1 2024 | 2024-03-31 | $2.4M | $525,340 | +28.19% |
| Q4 2023 | 2023-12-31 | $3.2M | $1.5M | +85.03% |
| Q3 2023 | 2023-09-30 | $3.2M | $1.9M | +135.61% |
| Q2 2023 | 2023-06-30 | $2.6M | $1.4M | +124.19% |
| Q1 2023 | 2023-03-31 | $1.9M | $721,746 | +63.21% |
| Q4 2022 | 2022-12-31 | $1.7M | $490,222 | +39.81% |
| Q3 2022 | 2022-09-30 | $1.4M | $518,528 | +60.67% |
| Q2 2022 | 2022-06-30 | $1.1M | $483,438 | +72.71% |
| Q1 2022 | 2022-03-31 | $1.1M | $572,482 | +100.55% |
| Q4 2021 | 2021-12-31 | $1.2M | — | — |
| Q3 2021 | 2021-09-30 | $854,618 | — | — |
| Q2 2021 | 2021-06-30 | $664,882 | — | — |
| Q1 2021 | 2021-03-31 | $569,351 | — | — |
DocGo r&d spending trends
Over the last five fiscal years, DocGo's r&d spending increased from $1.2M to $13.6M, a change of $12.4M. The latest reported quarter, Q2 2026, shows $3.4M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review DocGo source filings ↗